Reveromycin C is a natural product antibiotic isolated from Streptomyces culture broths along with Reveromycins A (sc-202314), B (sc-202315), and D (sc-202317). Reveromycin C is described to inhibit mitogenic activity in response to epidermal growth factor (EGF) with potency comparable to Reveromycins A and D (IC50 = 0.7~1.1 μg/ml) in Balb/MK cells. Inhibition of EGF function by Reveromycins is correlated to an antiproliferative effect.
1. Takahashi, H., et al. 1992. J. Antibiot. 45: 1409-1413. PMID: 1429225
2. Takahashi, H., et al. 1992. J. Antibiot. 45: 1414-1419. PMID: 1429226
3. Miyamoto, Y., et al. 2002. J. Biol. Chem. 277: 28810-28814. PMID: 12050165
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.